More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival
- 1 October 2018
- journal article
- conference paper
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 268 (4) , 632-639
- https://doi.org/10.1097/sla.0000000000002955
Abstract
To evaluate whether an association exists between the intensity of surveillance following surgical resection for non–small cell lung cancer (NSCLC) and survival. Surveillance guidelines following surgical resection of NSCLC vary widely and are based on expert opinion and limited evidence. A Special Study of the National Cancer Database randomly selected stage I to III NSCLC patients for data reabstraction. For patients diagnosed between 2006 and 2007 and followed for 5 years through 2012, registrars documented all postsurgical imaging with indication (routine surveillance, new symptoms), recurrence, new primary cancers, and survival, with 5-year follow-up. Patients were placed into surveillance groups according to existing guidelines (3-month, 6-month, annual). Overall survival and survival after recurrence were analyzed using Cox Proportional Hazards Models. A total of 4463 patients were surveilled with computed tomography scans; these patients were grouped based on time from surgery to first surveillance. Groups were similar with respect to age, sex, comorbidities, surgical procedure, and histology. Higher-stage patients received more surveillance. More frequent surveillance was not associated with longer risk-adjusted overall survival [hazard ratio for 6-month: 1.16 (0.99, 1.36) and annual: 1.06 (0.86–1.31) vs 3-month; P value 0.14]. More frequent imaging was also not associated with postrecurrence survival [hazard ratio: 1.02/month since imaging (0.99–1.04); P value 0.43]. These nationally representative data provide evidence that more frequent postsurgical surveillance is not associated with improved survival. As the number of lung cancer survivors increases over the next decade, surveillance is an increasingly important major health care concern and expenditure.Keywords
This publication has 20 references indexed in Scilit:
- Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of TreatmentJournal of Thoracic Oncology, 2016
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung CancerNew England Journal of Medicine, 2016
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groupsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Survival Benefits from Follow-Up of Patients with Lung Cancer: A Systematic Review and Meta-AnalysisJournal of Thoracic Oncology, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Protocole IFCT-0302 : essai randomisé de deux schémas de surveillance dans les cancers bronchiques non à petites cellules complètement réséquésRevue des Maladies Respiratoires, 2007
- Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner SocietyRadiology, 2005
- Revisions in the International System for Staging Lung CancerChest, 1997